XXT-18574-87694
6 vaccinations
9 coded responses
59 check-ins
9 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 145 / NY
- Registered
- 2021-02-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-17
Registered in v-safe
-
2021-02-17
Dose 1 — Moderna
-
2021-02-17
Health check-in — 0 day, dose 1Feeling: Good · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
-
2021-02-18
Survey response — days 1–6 daily, dose 1MedDRA: Adverse reaction — Feeling: Good · Site: Pain, Redness, Swelling · Be unable to do your normal daily activitiesMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-02-21
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Redness, Swelling · NoneAdult check-in
- 2021-02-22
- 2021-02-23
- 2021-02-24
-
2021-03-03
Survey response — 14 day, dose 1MedDRA: Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling — Feeling: GoodMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
- 2021-03-10
- 2021-03-17
-
2021-03-18
Dose 2 — Moderna
-
2021-03-18
Survey response — 0 day, dose 2MedDRA: Unevaluable event — Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-03-19
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-20
Survey response — days 1–6 daily, dose 2MedDRA: Adverse reaction — Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-03-21
Survey response — days 1–6 daily, dose 2MedDRA: Nausea — Feeling: Fair · Site: Pain · Fever · Chills, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-03-22
Survey response — days 1–6 daily, dose 2MedDRA: Oedema peripheral — Feeling: Good · Site: PainMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
- 2021-03-23
-
2021-03-24
Survey response — days 1–6 daily, dose 2MedDRA: Immunisation reaction — Feeling: GoodMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
- 2021-03-25
- 2021-04-01
- 2021-04-08
- 2021-04-15
- 2021-04-23
- 2021-04-29
- 2021-06-17
-
2021-08-26
Dose 3 — Moderna
-
2021-09-16
Survey response — 6 month, dose 2MedDRA: Headache, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activitiesMedDRA releases: 2024-11 · check-in answers available
- 2021-11-25
-
2022-03-31
Dose 4 — Pfizer-BioNTech
-
2022-04-15
Survey response — 14 day, dose 4MedDRA: Lymphadenopathy — Feeling: FairMedDRA releases: 2024-11 · check-in answers available
- 2022-04-21
- 2022-04-28
- 2022-05-05
- 2022-05-12
- 2022-06-30
-
2022-09-21
Dose 5 — Pfizer-BioNTech
- 2022-09-21
-
2022-09-22
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Site: Pain · Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2022-09-23
Health check-in — days 1–6 daily, dose 5Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-09-24
- 2022-09-25
- 2022-09-26
- 2022-09-27
- 2022-09-28
- 2022-10-05
- 2022-10-12
- 2022-10-19
- 2022-10-26
- 2022-11-02
- 2022-12-21
- 2023-03-22
-
2023-04-26
Dose 6 — Pfizer-BioNTech
- 2023-04-26
- 2023-04-27
- 2023-04-28
- 2023-04-29
- 2023-04-30
- 2023-05-01
- 2023-05-02
- 2023-05-03
- 2023-05-10
- 2023-05-17
- 2023-05-24
- 2023-05-31
- 2023-06-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-17 | Moderna | |
| 2 | 2021-03-18 | Moderna | |
| 3 | 2021-08-26 | Moderna | No |
| 4 | 2022-03-31 | Pfizer-BioNTech | No |
| 5 | 2022-09-21 | Pfizer-BioNTech | No |
| 6 | 2023-04-26 | Pfizer-BioNTech | No |
Free text
Release 4
Systemic reaction (other): Local reaction is not AROUND the area injected...its mostly to the SIDE of it (the side toward the body). Last night there were two distinct areas separated by 3 cm; today its one continuous area.
Release 5
Symptoms: Injection site reaction lasted 6 days then went away. On 2/27 (day 10) I had another reaction of itching, redness, swelling & some pain. Area was larger (8 cm x 3-6.5 cm) and is getting fainter but persists today. Reported to VAERS.
Systemic reaction (other): Symptoms began within 3 hours of vaccination...much more quickly than with vaccine #1.
Release 6
Systemic reaction (other): Some of the above symptoms have improved or gone away
Systemic reaction (other): Two episodes of acute nausea when getting out of bed...otherwise, its improved.
Systemic reaction (other): Swollen area under left axilla noted but no palpable lymph nodes
Systemic reaction (other): Outline of Moderna Arm reaction to first Covid shot is still faintly visible 26 days after it first appeared.
Release 9
Symptoms: Headache which started on day 9 of third Moderna vaccine (I am immunocompromised) and has continued for 12 days, now. I hardly ever get headaches so this is unusual.
Release 11
Symptoms: Swollen lymph nodes in neckstarted on 4/13/22.
Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | · | · | ✓ |
| SD | Injection site erythema | ✓ | ✓ | ✓ |
| SD | Injection site pain | ✓ | ✓ | ✓ |
| SD | Injection site pruritus | ✓ | ✓ | ✓ |
| SD | Injection site swelling | ✓ | ✓ | ✓ |
| SD | Lymphadenopathy | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SRO | Adverse reaction | ✓ | ✓ | ✓ |
| SRO | Immunisation reaction | ✓ | ✓ | ✓ |
| SRO | Nausea | ✓ | ✓ | ✓ |
| SRO | Oedema peripheral | ✓ | ✓ | ✓ |
| SRO | Unevaluable event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release